Literature DB >> 11237845

Experimental pneumococcal meningitis in mice: a model of intranasal infection.

P J Zwijnenburg1, T van der Poll, S Florquin, S J van Deventer, J J Roord, A M van Furth.   

Abstract

Effective laboratory animal models of bacterial meningitis are needed to unravel the pathophysiology of this disease. Previous models have failed to simulate human meningitis by using a directly intracerebral route of infection. Hyaluronidase is a virulence factor of Streptococcus pneumoniae. In this study, a novel model of murine meningitis is described. Intranasal administration of S. pneumoniae with hyaluronidase induced meningitis in 50% of inoculated mice, as defined by a positive cerebrospinal fluid (CSF) culture and an inflammatory infiltrate in the meninges. None of the mice inoculated without hyaluronidase developed meningitis. Hyaluronidase was found to facilitate pneumococcal invasion of the bloodstream after colonization of the upper respiratory tract. Meningitis was characterized by pleocytosis of CSF and the induction of proinflammatory cytokines and CXC chemokines in brain tissue. These results indicate that this murine model mimics important features of human disease and allow for the use of this model for studying issues related to the pathophysiology and the treatment of pneumococcal meningitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237845     DOI: 10.1086/319271

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

1.  RegR, a global LacI/GalR family regulator, modulates virulence and competence in Streptococcus pneumoniae.

Authors:  Sabine Chapuy-Regaud; A David Ogunniyi; Nicole Diallo; Yvette Huet; Jean-François Desnottes; James C Paton; Sonia Escaich; Marie-Claude Trombe
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

2.  Pathophysiology and treatment of bacterial meningitis.

Authors:  Olaf Hoffman; R Joerg Weber
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

3.  Streptococcus pneumoniae can utilize multiple sources of hyaluronic acid for growth.

Authors:  Carolyn Marion; Jason M Stewart; Mia F Tazi; Amanda M Burnaugh; Caroline M Linke; Shireen A Woodiga; Samantha J King
Journal:  Infect Immun       Date:  2012-02-06       Impact factor: 3.441

Review 4.  Chemotactic factors in cerebrospinal fluid during bacterial meningitis.

Authors:  Petra J G Zwijnenburg; Tom van der Poll; John J Roord; A Marceline van Furth
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

Review 5.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

6.  Conformational Change in the Active Site of Streptococcal Unsaturated Glucuronyl Hydrolase Through Site-Directed Mutagenesis at Asp-115.

Authors:  Yusuke Nakamichi; Sayoko Oiki; Bunzo Mikami; Kousaku Murata; Wataru Hashimoto
Journal:  Protein J       Date:  2016-08       Impact factor: 2.371

7.  cas9 Enhances Bacterial Virulence by Repressing the regR Transcriptional Regulator in Streptococcus agalactiae.

Authors:  Ke Ma; Qing Cao; Su Luo; Zhaofei Wang; Guangjin Liu; Chengping Lu; Yongjie Liu
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

Review 8.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

9.  Pneumococcal virulence gene expression and host cytokine profiles during pathogenesis of invasive disease.

Authors:  Layla K Mahdi; Abiodun D Ogunniyi; Kim S LeMessurier; James C Paton
Journal:  Infect Immun       Date:  2007-11-26       Impact factor: 3.441

10.  Distribution, genetic diversity, and variable expression of the gene encoding hyaluronate lyase within the Streptococcus suis population.

Authors:  Samantha J King; Andrew G Allen; Duncan J Maskell; Christopher G Dowson; Adrian M Whatmore
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.